SEC Filing Document

Company: Ambitious Entertainment, Inc.
Ticker: 
CIK: 1900851
Filing Type: DRS/A
Document Type: DRS/A
Date Filed: 2025-10-08
Accession Number: 0001493152-25-017387
Exchange: 
SIC Code: 7812
SIC Description: Services-Motion Picture & Video Tape Production
URL: https://www.sec.gov/Archives/edgar/data/1900851/000149315225017387/filename1.htm

Chunk 51 of 63
Word Count: 1471
Character Count: 9198

Document Content:

Offering (“IPO”). The Company determined our conversion feature for the convertible notes is not clearly and closely related to the host and accounted for it as a bifurcated derivative liability in accordance with ASC 815. During the year ended December 31, 2023, the Company issued convertible debt with principal balances ranging from approximately $25,000 to $111,000. Each debt instrument had the following terms (i) a one-year, 7% senior secured convertible promissory note in the aggregate amount of $25,000 per Unit purchased (the “Convertible Notes”) subject to an original issue discount of 10% (the “OID”), (ii) a five-year Series B warrant at an aggregate exercise price of $25,000 per Unit purchased, and (iii) a five-year Series C warrant at an aggregate exercise price of $25,000 per Unit purchased. Each Unit was immediately separable upon issuance. The Company received proceeds in the amount of $442,461 from the issuance of the convertible notes.

During
the year ended December 31, 2023, the Company also converted a loan payable in the amount of $75,000 to a convertible note with a principal
balance of $83,333, debt discount of $12,918, derivative liability of $500 and additional paid in capital of $4,085. The maturity date
of convertible notes issued in 2023 is one year from issuance date. As defined in the agreement, the conversion price is the 50% of offering
price per share of common stock paid in Initial Public Offering (“IPO”). The Company determined our conversion feature for
the convertible notes is not clearly and closely related to the host and accounted for it as a bifurcated derivative liability in accordance
with ASC 815.

During
the year ended December 31, 2024, the Company issued five convertible debt instruments with principal balances of $25,000. Each debt
instrument had the following terms (i) a one-year, 7% senior secured convertible promissory note in the aggregate amount of $25,000 per
Unit purchased (the “Convertible Notes”) subject to an original issue discount of 10% (the “OID”), (ii) a five-year
Series B warrant at an aggregate exercise price of $25,000 per Unit purchased, and (iii) a five-year Series C warrant at an aggregate
exercise price of $25,000 per Unit purchased. Each Unit was immediately separable upon issuance. The Company received proceeds in the
amount of $125,000 from the issuance of the convertible notes.

NOTE
9 - WARRANT

Series
A Warrants

During
the year ended December 31, 2021, the Company issued 5,600,000 Series A warrants for $56,000. Subsequent to their issuance, these warrants
were amended to prefunded warrants. As part of the amendment, the number of warrants was reduced to 4,000,000, and the exercise terms
were revised. The Series A Warrants are five-year warrants that are immediately vested and exercisable at a nominal exercise price of
$0.001 per share. These warrants may also be exercised on a cashless basis.

of December 31, 2024, and 2023, the Company has 4,000,000 Series A warrants outstanding.

Series
B Warrants (Units)

The
Series B Warrants are five-year warrants that are immediately vested and exercisable at an exercise price equal to 110% of the Conversion
Price of the Convertible Notes with an aggregate purchase price of $25,000 per Unit. These warrants can be exercised on a cashless basis.

of December 31, 2024, and 2023, the Company has 76 and 71 Series B warrants outstanding, respectively.

Series
C Warrants (Units)

The
Series C Warrants are five-year warrants that are immediately vested and exercisable at an exercise price equal to 110% of the Conversion
Price of the Convertible Notes with an aggregate purchase price of $25,000 per Unit. These warrants can be exercised on a cashless basis.

of December 31, 2024, and 2023, the Company has 76 and 71 Series C warrants outstanding, respectively.

The
Series A, B and C Warrants have been accounted for as a derivative liability, in accordance with ASC 815.

summary of activity of the warrants during the year ended December 31, 2024, and 2023, are as follows:

Warrants Outstanding Weighted Average

Number of Weighted Average Remaining life

Warrants Exercise Price (years)

Outstanding, December 31, 2022 4,000,098 $	0.001 3.17

Granted 44 0.001 -

Expired / cancelled - - -

Exercised - - -

Outstanding, December 31, 2023 4,000,142 $	0.001 2.17

Granted 10 0.001 -

Expired / cancelled - - -

Exercised - - -

Outstanding, December 31, 2024 4,000,152 $	0.001 1.16

Granted 4 0.001 -

Expired / cancelled - - -

Exercised - - -

Outstanding, March 31, 2025 4,000,156 $	0.001 0.16

The
intrinsic value of the warrants as of December 31, 2024, is $0. All of the outstanding warrants are exercisable as of December 31, 2024.

NOTE
10 – DERIVATIVE LIABILITY

Fair
Value Assumptions Used in Accounting for Derivative Liabilities

ASC
815 requires the Company to assess the fair market value of derivative liabilities at the end of each reporting period and recognize
any change in fair market value as other income or expense. The Company determined that our derivative liabilities are classified as
Level 3 fair value measurements and used the Black-Scholes pricing model to calculate the fair value as of issuance and at December 31,
2024, and 2023.

The
Black-Scholes model requires six basic data inputs: the exercise or strike price, time to expiration, the risk-free interest rate, the
current stock price, the estimated volatility of the stock price in the future, and the dividend rate. Changes to these inputs could
produce significantly higher or lower fair value measurements.

Key
assumptions and methodologies used are as follows:

●	Stock
Price : Based on historical issuances.

●	Expected
Volatility : Estimated using historical stock price volatility of comparable companies, as our stock does not have sufficient
historical trading activity.

●	Risk-Free
Interest Rate : Derived from U.S. Treasury rates for the applicable periods.

Sensitivity
Analysis

The
fair value of derivative liabilities is sensitive to changes in key inputs:

●	Volatility :
A 5% increase (decrease) in volatility would increase (decrease) the fair value by approximately $30,000.

●	Risk-Free
Rate : A 50-basis point increase (decrease) in the risk-free interest rate would increase (decrease) the fair value by approximately

The
inputs used to calculate the derivative values are as follows:

Years ended

December 31,

Stock price $	0.79 - 2.50 $	0.61 - 2.50

Expected term 0.26 - 3.17 0.26 - 3.17

Expected average volatility 66	% 64	%

Expected dividend yield - -

Risk-free interest rate 3.88 - 5.25% 0.7 1 - 3.00%

The
following table summarizes the changes in the derivative liabilities during the year ended December 31, 2024, and 2023:

Fair Value Measurements Using Significant Unobservable Inputs (Level 3)

Balance – January 1, 2023 $	4,349,390

Addition of new derivatives recognized as warrants 1,101,262

Addition of new derivatives recognized as conversion feature 344,145

Loss on change in fair value of the derivative 2,113,633

Balance - December 31, 2023 $	7,908,430

Addition of new derivatives recognized as warrants 277,578

Addition of new derivatives recognized as conversion feature 86,743

Loss on change in fair value of the derivative 201,422

Balance - December 31, 2024 $	8,474,173

The
aggregate loss on derivatives during the years ended December 31, 2024, and 2023 was as follows.

December 31,

Change in fair value of the derivative $	211,422 $	2,606,094

Day 1 loss due to derivative liabilities 354,321 952,946

NOTE
11 – EQUITY

Authorized
Capital Stock

Effective
October 2020, the Company filed a Certificate of Amendment to the Articles of Incorporation for authorized capital stock to authorize
the Company to issue 151,000,000 shares. The Company has authorized 150,000,000 shares of common stock with a par value of $0.0001 per
share and 1,000,000 shares of Preferred Stock with a par value of $0.0001 per share. The
Company shall have the authority to issue the shares of Preferred Stock in one or more series with such rights, preferences and designations
as determined by the Board of Directors of the Company.

Series
A Preferred Stock

Effective
October 2020, the Company filed a Certificate of Amendment to the Articles of Incorporation for authorized capital stock to authorize
the Company to issue 151,000,000 shares. The Company has authorized 150,000,000 shares of common stock with a par value of $0.0001 per
share and 1,000,000 shares of Preferred Stock with a par value of $0.0001 per share. The
Company shall have the authority to issue the shares of Preferred Stock in one or more series with such rights, preferences and designations
as determined by the Board of Directors of the Company.

Series
A Preferred Stock

The
Company has designated 1,000,000 preferred shares, par value $0.0001, as Series A Preferred Stock. Holders of Series A Preferred Stock
would have the right to vote with 1 vote per common share on any matters brought before the stockholders of the Company.

The
Series A Preferred Stockholders are not entitled to any dividends, mandatory conversion right, or liquidation preference, however, they
do have a voluntary conversion right.